FindTrial
Sign In

Study of the Clinical Efficacy of Autologous SCT in Patients With Critical Limb Ischemia

Phase II Prospective Study of the Clinical Efficacy of Autologous SCT in Patients With Critical Limb Ischemia

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01311011
Enrollment
26
Registered
2011-03-09
Start date
2008-11-30
Completion date
Unknown
Last updated
2011-12-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Critical Limb Ischemia

Keywords

Critical Limb Ischemia

Brief summary

Phase II Prospective Study of the Clinical Efficacy of Autologous SCT in patients with Critical Limb Ischemia

Detailed description

Phase II Prospective Study of the Clinical Efficacy of Autologous SCT in patients with Critical Limb Ischemia

Interventions

PROCEDURESCT

SCT

Sponsors

King Faisal Specialist Hospital & Research Center
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
14 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* Patients with Critical Limb Ischemia

Exclusion criteria

* Patients with other than Critical Limb Ischemia

Countries

Saudi Arabia

Contacts

Primary ContactH Al-Zahrani, M.D.
+966-1-4423949

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026